The 18-month-old girl was found in a ‘critical condition’ inside the vehicle in Almada on the southern bank of the Tagus River directly opposite the capital Lisbon (Picture: Getty Images)
Wildfires have ravaged much of the UK and Europe this week,and southern Italy is no exception.
But authorities are now investigating whether the flames may have been spread deliberately – and in a ra
Highlights:
Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 inAmyotrophic Lateral Sclerosis
BEIJING,Nov. 11,2024-- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"),a leading global Hologram Augmented Reality ("AR") Technology provider,has develo
SINGAPORE,Nov. 12,2024--Globe Teleservices (GTS),a leading global telecom solutions provider,is thrilled to announce the signing of an exclusive 3-year contract with XOX Malaysia,a leading mobile virt
DENVER,Nov. 8,2024-- The World Agility Open (WAO),one of the largest annual international dog agility competitions,is proud to announce that FitPaws has committed to sponsoring the event through 2026
SHANGHAI,Nov. 8,2024-- On the morning of November 7,at the 7th China International Import Expo (CIIE),Henlius (2696.HK) entered into a strategic collaboration with AL-TIRYAQ AL-KHALAWI Medical Company
YANTAI,China,Nov. 11,2024-- As a company dedicated to social responsibility,Wanhua Chemical has consistently supported the communities in which it operates. This fall,Wanhua Chemical collaborated with
PISCATAWAY,N.J.,Nov. 11,2024-- GenScript Biotech Corporation ("GenScript"),a global leader in life sciences services and products,has announced the establishment of new operations site and l
BEIJING,Nov. 11,2024-- A report from en.qstheory.cn:
Jiangxi Province\'s Jingdezhen is renowned as China\'s "Porcelain Capital". In its central area lies the Taoyangli Historical and Cultura
TAIPEI,Nov. 4,2024-- On November 1,2024,ARTERY Technology,in partnership with its Korean distributorIGM,successfully hosted the "2024 AT32 MCU Application Training" in Seoul. The event focus
SHANGHAI,Nov. 5,2024-- BioCity Biopharma (BioCity) announced late-breaking results of the 2-SUCCEED clinical trial of SC0062,a selective endothelin receptor type A (ETA) antagonist,for the treatment o